Join companies like...
Abbott – Alligator Bioscience − Arbor Pharmaceuticals – Astellas Pharma – AstraZeneca − Cumulus Oncology − Daiichi Sankyo – Dare Bioscience – Debiopharm – Eli Lilly & Company – Eudendron − Genoscience Pharma − GLG Pharma − Inflection Biosciences Ltd − InterVenn Biosciences − Kitov Pharma – LEUKOCARE – Maat Pharma – MedinCell − NeoImmuneTech, Inc. – Novartis – Nippon Kayaku Co., Ltd. – Oncimmune − Orphagen Pharmaceuticals − PCI Biotech − Prescient Therapeutics − Salarius Pharmaceuticals − Salipro Biotech − Sermonix Pharmaceuticals – Transcenta
Companies profile
Attendees profile
Asset phase
Why participate?
Find potential R&D collaborations or oncology assets available for in-licensing/acquisition
Identify partners with research solutions such as high throughput screening tools, clinical research capacity, or animal models
Secure funding from new investors or find licensing partners for your portfolio
Discover new diagnostics, biomarkers, adjuvants, carrier systems or technologies
Who will attend?
The Oncology Virtual Partnering Event will bring these stakeholders together to pursue:
Potential R&D collaborations
Early stage discovery collaboration
Drug repurposing
Biological markers and diagnostic tests
Adjuvants, carrier systems, and formulation technologies
Tools for research projects
Animal and in-silico models
Funding and investors
Partners for clinical trials